ADC Telecommunications

(ADCT) - Get ADC Therapeutics SA Report

was down 4% in late morning trading after

Josephthal

TheStreet Recommends

downgraded it to buy from strong buy and cut its 12-month target to $28 from $45. The company on Friday said it laid off workers in two divisions to cut costs.